Jennifer Schneider is the founder of Centauri Therapeutics. Centauri Therapeutics has raised $38M in total funding. Latest round: Series A.
Jennifer Schneider is the Chief Executive Officer and Co-founder of Centauri Therapeutics, an immunotherapy company based in London, England. She leads the company's strategic direction and clinical progress, including the advancement of lead candidate CTX-09 targeting Gram-negative bacteria.
Full founder directory · Investor directory · Company funding database · Fundraising library